Clincosm LogoSign in Get a demo

Neoplasms

Showing NaN - NaN of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Tumors Trial in Worldwide (Dostarlimab)

Recruiting
  • Neoplasms
  • Dostarlimab
  • Birmingham, Alabama
  • +105 more
Nov 17, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel (lete-cel, GSK3377794)
  • +2 more
  • Duarte, California
  • +36 more
Oct 28, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Tumors Trial in United States (Niraparib, Pembrolizumab, TSR-042 (Dostarlimab))

Completed
Has Results
  • Neoplasms
  • Whittier, Alaska
  • +15 more
Aug 29, 2022

Tumors, NSCLC, Pancreatic Tumors Trial in Worldwide (V941, Pembrolizumab)

Completed
  • Neoplasms
  • +3 more
  • V941
  • Pembrolizumab
  • Gilbert, Arizona
  • +25 more
Sep 5, 2022

Tumors Trial in Worldwide (GSK6097608, Dostarlimab, GSK4428859A (EOS884448))

Recruiting
  • Neoplasms
  • Los Angeles, California
  • +9 more
Aug 26, 2022

Tumors Trial in Australia, Canada, United States (feladilimab, Tremelimumab, Docetaxel)

Completed
Has Results
  • Neoplasms
  • Boston, Massachusetts
  • +7 more
Jul 28, 2022

Tumors Trial in Worldwide (Biopsy)

Completed
  • Neoplasms
  • Biopsy
  • San Francisco, California
  • +10 more
Aug 10, 2022

Tumors, Breast Tumors, Breast Tumors, Triple-Negative Trial in Korea, Republic of, Spain, United States (CX-2009, CX-072)

Active, not recruiting
  • Neoplasms
  • +4 more
  • La Jolla, California
  • +41 more
Aug 5, 2022

Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

Recruiting
  • Neoplasms
  • Gene-modified (GM) T cell therapy
  • Birmingham, Alabama
  • +173 more
Aug 1, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Tumors, Neutropenia Trial in Boston (PointCheck)

Recruiting
  • Neoplasms
  • Neutropenia
  • PointCheck
  • Boston, Massachusetts
    Boston Medical Center
Apr 6, 2022

Tumors Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 [PD-L1] antibody, MOXR0916, a

Completed
  • Neoplasms
  • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 [PD-L1] antibody
  • MOXR0916, a humanized agonist anti-OX40 monoclonal antibody
  • Scottsdale, Arizona
  • +26 more
Mar 31, 2022

Solid Tumors, Colorectal Cancer, Breast Cancer Trial in Canada, United States (LY2880070, Gemcitabine)

Completed
  • Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Tumors, Coronavirus Trial in United States

Recruiting
  • Neoplasms
  • Coronavirus
    • Birmingham, Alabama
    • +84 more
    Feb 23, 2022

    Tumors Trial in Canada, United States (GSK3326595, 5-Azacitidine)

    Terminated
    • Neoplasms
    • Birmingham, Alabama
    • +7 more
    Feb 10, 2022

    Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

    Active, not recruiting
    • Ewing Sarcoma
    • +12 more
    • Vigil
    • +2 more
    • Little Rock, Arkansas
    • +16 more
    Feb 9, 2022

    Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)

    Completed
    Has Results
    • Neoplasms
    • Veliparib + VX-970 + Cisplatin
    • Bethesda, Maryland
    • +2 more
    Jan 14, 2022

    Tumors Trial in Worldwide (GSK adoptive cell therapy)

    Recruiting
    • Neoplasms
    • GSK adoptive cell therapy
    • Duarte, California
    • +37 more
    Feb 1, 2022